Neutrophil activity in chronic venous leg ulcers—A target for therapy?
- 28 March 2013
- journal article
- review article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 21 (3) , 339-351
Abstract
Chronic venous leg ulcers (CVLUs) affect approximately 600,000 people annually in the United States and accrue yearly treatment costs of US$2.5–5 billion. As the population ages, demands on health care resources for CVLU treatments are predicted to drastically increase because the incidence of CVLUs is highest in those ≥65 years of age. Furthermore, regardless of current standards of care, healing complications and high recurrence rates prevail. Thus, it is critical that factors leading to or exacerbating CVLUs be discerned and more effective, adjuvant, evidence‐based treatment strategies be utilized. Previous studies have suggested that CVLUs' pathogenesis is related to the prolonged presence of high numbers of activated neutrophils secreting proteases in the wound bed that destroy growth factors, receptors, and the extracellular matrix that are essential for healing. These events are believed to contribute to a chronically inflamed wound that fails to heal. Therefore, the purpose of this project was to review studies from the past 15 years (1996–2011) that characterized neutrophil activity in the microenvironment of human CVLUs for new evidence that could explicate the proposed relationship between excessive, sustained neutrophil activity and CVLUs. We also appraised the strength of evidence for current and potential therapeutics that target excessive neutrophil activity.Keywords
This publication has 121 references indexed in Scilit:
- Fish oil supplementation alters levels of lipid mediators of inflammation in microenvironment of acute human woundsWound Repair and Regeneration, 2011
- Resolvins and protectins: mediating solutions to inflammationBritish Journal of Pharmacology, 2009
- Redox signals in wound healingBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Multiplexed analysis of matrix metalloproteinases in leg ulcer tissue of patients with chronic venous insufficiency before and after compression therapyWound Repair and Regeneration, 2008
- Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and plateletsBlood, 2008
- Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature, 2007
- The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: Novel oxygenase products from ω-3 polyunsaturated fatty acidsBiochemical and Biophysical Research Communications, 2005
- Iron and 8-Isoprostane Levels in Acute and Chronic WoundsJournal of Investigative Dermatology, 2003
- Topically Applied Cmt-2 Enhances Wound Healing in Streptozotocin Diabetic Rat SkinAdvances in Dental Research, 1998
- Tissue Destruction by NeutrophilsNew England Journal of Medicine, 1989